“…MOFs with biocompatible composition were reported to be viable drug carriers to overcome some of the problems related to drug delivery [ 9 , 20 , 21 , 22 ]. In particular, MOFs designed using antibiotics as ligands to yield antibiotic coordination frameworks (ACFs) were proposed to improve the antimicrobial activity [ 23 , 24 , 25 ], as well as the physicochemical properties of the antibiotics [ 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 ].…”